pMTA
Percutaneous Microwave Tissue Ablation
The percutaneous version of the MTA system was CE Marked in February 2010 and is now in full distribution in Europe and other jurisdictions that follow the CE Mark. FDA 510(k) submissions are under review by the FDA and clearance is expected in mid 2010.
This design brings the benefits of Microwave ablation into the realm of the interventional radiologist with application in liver, lung, bone, kidney and any other sites where local tumour control can be secured using volume ablation.
Our device is a 1.8mm diameter closed water cooled needle with performance matching the existing open surgery MTA system. It benefits from the extreme ease of use and operation of the Acculis System.
Watch this space for further updates.
